1) 厚生統計協会:国民衛生の動向. 厚生の指標. 臨時増刊 50(9):40-64,2003
2) 平成14年人口動態統計月報年計 (概数) の概況 (Accessed September 3, 2003, at http://www.mhiw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai02/)
3) Centers for Disease Control and Prevention:Pneumonia and influenza death rates:United State, 1979-1994. MNWR Morb Mortal Wky Rep 44:535-537, 1995.
5) 日本呼吸器学会:成人市中肺炎診療の基本的な考え方. 日本呼吸器学会呼吸器感染症に関するガイドライン作成委員会編, 2000.
6) Levy M, et al:Community-acuired pneumnia. Importance of initial noninvasive bacteriologic and radiographic investigations. Chest 92:43, 1988
7) Marie T J, et al:Community-acquired pneumoia requiring hospitalization 5-year prospective study. Rev Infect Dis 11:586-599, 1989.
9) Fang G D, et al:New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69:307-316, 1990.
10) Marston B J, et al:Incidence of community acquired pneumonia requiring hospialization. Rsults of a population-based active surveillance study in Ohio, Arch Intern Med 157:1709-1718, 1997.
12) Porath A, et al:The epidemiology of community-acquired pneumonia among hospitalized adults. J Infect 34:41-48, 1997.
13) Ishida T, et al:Etiology of community-acquired pneumonia in hospitalized patients. A 3-year prospective study in Japan. Chest 114:1588-1593, 1998.
14) Miyashita N, et al:Etiology of communityacquired pneumonia requiring hospitalization in Japan. Chest 119:1295-1296, 2000.
15) 日本呼吸器学会:成人院内肺炎診療の基本的な考え方. 日本呼吸器学呼吸器感染症に関するガイドライン作成委員会編. 2002
16) 島田馨他:呼吸器感染症分離菌の薬剤感受性について (2000年). Jpn J Antibiotics 55:537-567, 2002."
17) PROTEKT resistance surveillance (Accessed September 3, 2003, at http://www. protekt. org/index1. htm)
19) Hoban D, et al:Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000:findings of the PROTEKT surveillance study. Diagn Microbiol Infect Dis 45:251-259, 2003.
20) Blondeau J M, et al:Antimicrobial susceptibility patterns of respiratory pathgens-A global perspective. Semin Respir Infect 15:195-207, 2000.
21) 生方公子:肺炎球菌, インフルエンザ菌の疫学的考察. Jpn J Antibiotics 54:4-10, 2001.
22) 中野哲治, 他:メタロβラクタマーゼ遺伝子 blaIMP陽性グラム陰性桿菌検出症例の臨床的検討. 感染症誌 75:946-954, 2001.
23) Spanu T, et al:Occurrence of extended-spectrum β-lactamases in members of the family Enterobacteriaceae in Italy:Implication fbr resistance to β-lactams and other antimicrobial drugs. Antimicrob Agents Chemother 46:196-202, 20
24) Hoban D J, et al:Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America:results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn Microbiol Infect Dis 45:279-285, 2003.